Back to Search
ANDREW NORDEN, MD
MD
Neurology Physician
NPI: 1497737456IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
220674(MA)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
Colon perforation during antiangiogenic therapy for malignant glioma.
PMID 18757774·Neuro Oncol·2009
5-case
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma.
PMID 19043778·J Neurooncol·2009
8-other
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
PMID 18316689·Neurology·2008
4-observational
Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome.
PMID 11752029·J Am Soc Nephrol·2002
8-other
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.
PMID 19332770·Neuro Oncol·2009
8-other
Therapeutic strategies for inhibiting invasion in glioblastoma.
PMID 19344303·Expert Rev Neurother·2009
8-other
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
PMID 19293394·Neuro Oncol·2009
3-trial
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.
PMID 18513880·Int J Radiat Oncol Biol Phys·2009
3-trial
Phase II study of protracted daily temozolomide for low-grade gliomas in adults.
PMID 19118062·Clin Cancer Res·2009
3-trial
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.
PMID 19221865·J Neurooncol·2009
8-other
Antiangiogenic strategies for treatment of malignant gliomas.
PMID 19560741·Neurotherapeutics·2009
6-review
DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.
PMID 18779600·J Clin Oncol·2008
5-case
Emerging antiangiogenic treatments for gliomas - efficacy and safety issues.
PMID 19060566·Curr Opin Neurol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 725 ALBANY ST, SUITE 7B, SHAPIRO BLDG
BOSTON, MA 02118 - Phone
- (617) 638-8456
Quick Facts
- NPI
- 1497737456
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile